eFFECTOR Therapeutics (EFTR) Competitors $0.0002 0.00 (0.00%) As of 10/8/2025 02:21 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock EFTR vs. AMPE, CMRA, PXMD, CLVR, HSTO, ATNFW, LBPSW, AIMDW, ALVOW, and ARAVShould you be buying eFFECTOR Therapeutics stock or one of its competitors? The main competitors of eFFECTOR Therapeutics include Ampio Pharmaceuticals (AMPE), Comera Life Sciences (CMRA), PaxMedica (PXMD), Clever Leaves (CLVR), Histogen (HSTO), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Ainos (AIMDW), Alvotech (ALVOW), and ARAVIVE (ARAV). These companies are all part of the "pharmaceutical products" industry. eFFECTOR Therapeutics vs. Its Competitors Ampio Pharmaceuticals Comera Life Sciences PaxMedica Clever Leaves Histogen 180 Life Sciences 4D pharma Ainos Alvotech ARAVIVE eFFECTOR Therapeutics (NASDAQ:EFTR) and Ampio Pharmaceuticals (NYSE:AMPE) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, analyst recommendations, media sentiment and institutional ownership. Does the media refer more to EFTR or AMPE? In the previous week, eFFECTOR Therapeutics' average media sentiment score of 0.00 equaled Ampio Pharmaceuticals'average media sentiment score. Company Overall Sentiment eFFECTOR Therapeutics Neutral Ampio Pharmaceuticals Neutral Do insiders & institutionals have more ownership in EFTR or AMPE? 57.7% of eFFECTOR Therapeutics shares are held by institutional investors. Comparatively, 5.7% of Ampio Pharmaceuticals shares are held by institutional investors. 4.7% of eFFECTOR Therapeutics shares are held by company insiders. Comparatively, 3.3% of Ampio Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has higher earnings and valuation, EFTR or AMPE? Ampio Pharmaceuticals is trading at a lower price-to-earnings ratio than eFFECTOR Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioeFFECTOR TherapeuticsN/AN/A-$35.81M-$13.080.00Ampio PharmaceuticalsN/AN/A-$8.63M-$11.010.00 Which has more volatility & risk, EFTR or AMPE? eFFECTOR Therapeutics has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500. Comparatively, Ampio Pharmaceuticals has a beta of 5.13, indicating that its share price is 413% more volatile than the S&P 500. Is EFTR or AMPE more profitable? Company Net Margins Return on Equity Return on Assets eFFECTOR TherapeuticsN/A N/A N/A Ampio Pharmaceuticals N/A N/A N/A SummaryeFFECTOR Therapeutics and Ampio Pharmaceuticals tied by winning 3 of the 6 factors compared between the two stocks. Get eFFECTOR Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EFTR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EFTR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EFTR vs. The Competition Export to ExcelMetriceFFECTOR TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1K$1.05B$6.09B$10.54BDividend YieldN/A4.84%5.69%4.71%P/E Ratio0.001.2685.3527.60Price / SalesN/A148.70539.78202.41Price / CashN/A17.6437.9261.55Price / Book0.007.5213.016.76Net Income-$35.81M-$7.77M$3.30B$275.88M7 Day PerformanceN/A26.65%4.34%2.81%1 Month PerformanceN/A27.91%9.49%9.24%1 Year PerformanceN/A-5.66%84.83%35.42% eFFECTOR Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EFTReFFECTOR Therapeutics0.0662 of 5 stars$0.00flatN/A-99.5%$1KN/A0.0010AMPEAmpio PharmaceuticalsN/A$0.00flatN/A+22.7%$3KN/A0.0020CMRAComera Life SciencesN/AN/AN/AN/A$3K$1.00M0.002PXMDPaxMedicaN/AN/AN/AN/A$2KN/A0.002CLVRClever Leaves0.2916 of 5 stars$0.00-75.0%N/AN/A$1K$17.42M0.00560Gap DownHSTOHistogenN/A$0.00flatN/A-99.9%$1K$19K0.0020ATNFW180 Life SciencesN/A$0.08+0.1%N/A+873.0%$0.00N/A0.007LBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAIMDWAinosN/A$0.19+37.0%N/A+380.0%$0.00$110.87K0.0040Positive NewsGap UpALVOWAlvotechN/A$1.52+26.6%N/A-51.2%$0.00$560.10M0.004Positive NewsGap DownHigh Trading VolumeARAVARAVIVEN/A$0.04flatN/AN/A$0.00$9.14M0.0020High Trading Volume Related Companies and Tools Related Companies Ampio Pharmaceuticals Alternatives Comera Life Sciences Alternatives PaxMedica Alternatives Clever Leaves Alternatives Histogen Alternatives 180 Life Sciences Alternatives 4D pharma Alternatives Ainos Alternatives Alvotech Alternatives ARAVIVE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EFTR) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding eFFECTOR Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share eFFECTOR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
